pI: 6.9254 |
Length (AA): 331 |
MW (Da): 36558 |
Paralog Number:
8169
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Sus scrofa | Elastase 2A | 269 aa | 24.5% | 253 aa | Compounds | References |
Bos taurus | Beta-chymotrypsin | 245 aa | 24.2% | 240 aa | Compounds | References |
Rattus norvegicus | Elastase 2A | 271 aa | 23.3% | 253 aa | Compounds | References |
Sus scrofa | Elastase 1 | 266 aa | 21.4% | 257 aa | Compounds | References |
Sus scrofa | Pancreatic elastase | 269 aa | 24.5% | 253 aa | Compounds | References |
Canis lupus familiaris | Coagulation factor X | 159 aa | 27.0% | 137 aa | Compounds | References |
Bos taurus | Alpha-chymotrypsin | 245 aa | 25.2% | 250 aa | Compounds | References |